The Burden of Malaria Transmission due to Asymptomatic HIV Co-Infection

无症状艾滋病毒合并感染导致疟疾传播的负担

基本信息

项目摘要

DESCRIPTION (provided by applicant): The public health crisis of malaria-HIV co-infection is rapidly expanding in sub-Saharan Africa. Lowland western Kenya in particular is holoendemic for malaria transmission and is plagued with catastrophically high rates of HIV/AIDS infection. A 2006 mathematical model of transmission in this region retrospectively predicted that co-infection has resulted in a cumulative excess of 8,500 HIV-1 infections and 980,000 malaria episodes since 1980. Individuals infected with HIV experience more frequent and more severe episodes of clinical malaria and the risk increases with advancing HIV disease. However, our pilot studies and a significant body of published data also suggest that specific increases in asymptomatic parasitemias and gametocytemias also are likely to occur in HIV-infected individuals in malaria-holoendemic areas. While numerous studies have examined one or more of the complicating aspects of co-infection and symptomatic malaria in cross-sectional studies, no studies have attempted to determine the longitudinal epidemiological impact of co-infection on asymptomatic malaria and specifically on malaria transmission in regions characterized by high transmission of both diseases and by increasing antimalarial drug resistance. Antifolates are widely prescribed for prophylaxis of HIV-associated opportunistic infections, yet they are also known to increase the appearance of gametocytes. We hypothesize that co-infection with HIV, and associated therapy, could be directly responsible for significant increases in asymptomatic parasite carriage and gametocytemia as well as increased antifolate- resistant parasite genotypes and, therefore, contribute directly to the increased burden of falciparum malaria. To this end, we propose to focus complementary clinical and entomological studies using highly sensitive and specific molecular tools in a highly endemic area of western Kenya to assess point and longitudinal prevalence's of co-infection in general and gametocytemia in particular with an emphasis on longitudinal risk of malaria transmission in the context of prevailing HIV therapies.
描述(由申请人提供):疟疾-艾滋病毒合并感染的公共卫生危机正在撒哈拉以南非洲迅速扩大。特别是肯尼亚西部的低地是疟疾传播的地方病,艾滋病毒/艾滋病感染率高得令人灾难。2006年该地区的一个传播数学模型回顾性地预测,自1980年以来,合并感染已导致累计超过8 500例HIV-1感染和980 000例疟疾发作。感染艾滋病毒的个人经历更频繁和更严重的临床疟疾发作,风险随着艾滋病毒疾病的进展而增加。然而,我们的试点研究和大量已发表的数据也表明,在疟疾全流行地区的艾滋病毒感染者中,无症状寄生虫血症和配子体血症也可能发生特定的增加。虽然许多研究在横断面研究中审查了合并感染和有症状疟疾的一个或多个复杂方面,但没有研究试图确定合并感染对无症状疟疾的纵向流行病学影响,特别是在这两种疾病传播率高和抗疟药物抗药性增加的地区对疟疾传播的影响。抗叶酸剂被广泛用于预防HIV相关的机会性感染,但它们也被认为会增加配子体的出现。我们假设,合并感染HIV和相关治疗可能直接导致无症状寄生虫携带和配子体血症的显著增加以及抗叶酸剂耐药寄生虫基因型的增加,因此,直接导致恶性疟疾负担的增加。为此,我们建议集中互补的临床和昆虫学研究,在肯尼亚西部的一个高度流行的地区,使用高度敏感和特异性的分子工具,以评估点和纵向的共同感染的患病率一般和配子体血症,特别是在流行的艾滋病毒治疗的背景下,疟疾传播的纵向风险的重点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shirley Luckhart其他文献

Shirley Luckhart的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shirley Luckhart', 18)}}的其他基金

How to starve a parasite: Manipulating CoA biosynthesis to control Plasmodium development in the mosquito
如何让寄生虫挨饿:操纵 CoA 生物合成来控制蚊子体内疟原虫的发育
  • 批准号:
    10656980
  • 财政年份:
    2023
  • 资助金额:
    $ 53.39万
  • 项目类别:
Biogenic amines, malaria and manipulation of mosquito physiology and behavior.
生物胺、疟疾以及蚊子生理和行为的控制。
  • 批准号:
    10679076
  • 财政年份:
    2022
  • 资助金额:
    $ 53.39万
  • 项目类别:
Biogenic amines, malaria and manipulation of mosquito physiology and behavior.
生物胺、疟疾以及蚊子生理和行为的控制。
  • 批准号:
    10515589
  • 财政年份:
    2022
  • 资助金额:
    $ 53.39万
  • 项目类别:
Midgut mitochondrial function as a driver of resistance and fitness in mosquitoes
中肠线粒体功能作为蚊子抵抗力和健康的驱动因素
  • 批准号:
    9752692
  • 财政年份:
    2018
  • 资助金额:
    $ 53.39万
  • 项目类别:
Malaria and allergic inflammatory changes to the gut barrier
疟疾和过敏性炎症对肠道屏障的改变
  • 批准号:
    10170213
  • 财政年份:
    2018
  • 资助金额:
    $ 53.39万
  • 项目类别:
Harnessing midgut mitochondrial dynamics to enhance Anopheline mosquito fitness
利用中肠线粒体动力学增强按蚊的适应性
  • 批准号:
    8881816
  • 财政年份:
    2014
  • 资助金额:
    $ 53.39万
  • 项目类别:
Fluidigm BioMark HD MX/HX Real-Time PCR System
Fluidigm BioMark HD MX/HX 实时 PCR 系统
  • 批准号:
    8446862
  • 财政年份:
    2013
  • 资助金额:
    $ 53.39万
  • 项目类别:
The Burden of Malaria Transmission due to Asymptomatic HIV Co-Infection
无症状艾滋病毒合并感染导致疟疾传播的负担
  • 批准号:
    8711275
  • 财政年份:
    2012
  • 资助金额:
    $ 53.39万
  • 项目类别:
The Burden of Malaria Transmission due to Asymptomatic HIV Co-Infection
无症状艾滋病毒合并感染导致疟疾传播的负担
  • 批准号:
    8466428
  • 财政年份:
    2012
  • 资助金额:
    $ 53.39万
  • 项目类别:
EFFECTS OF MALARIA ON PARASITE INFECTION ON INTESTINAL RESPONSE
疟疾寄生虫感染对肠道反应的影响
  • 批准号:
    8357364
  • 财政年份:
    2011
  • 资助金额:
    $ 53.39万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了